Tapaginseng 10 mg (Dapagliflozin Propanediol Hydrate)

Adult dose

The recommended dose of this medication is 10 mg once daily for monotherapy and additional combination therapy with insulin or other glucose-lowering medications. In initial combination therapy, the dose is 5 mg once daily or 10 mg once daily. Patients with chronic heart failure and chronic kidney disease should also take 10 mg once daily. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended; it can later be increased to 10 mg if tolerable.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no related data.

This medication should not be used in specific patients. Patients who have had allergic reactions to the active ingredient or additives of this medication, those with Type 1 diabetes, patients with diabetic ketoacidosis, and patients on dialysis should not take this medication. Patients with reduced fluid volume or issues with kidney function should use this medication cautiously. This medication may lower blood pressure or cause changes in serum creatinine levels, which could stress the kidneys; therefore, kidney function and blood pressure should be carefully monitored before and during treatment. Taking this medication may increase the risk of genital infections or urinary tract infections. If infection symptoms appear, consult a healthcare professional immediately. When used with medications that have risks of hypoglycemia, care should be taken to prevent blood sugar levels from dropping too low, and adjustments to doses of other diabetes medications may be necessary. Pregnant or nursing women are advised not to use this medication, and it should be discontinued immediately if pregnancy is confirmed. Elderly patients have a higher risk of kidney function decline and fluid volume reduction, thus greater caution is required when taking this medication. If symptoms of fluid volume reduction or hypotension occur, immediate notification is necessary, and the medication may be temporarily halted if needed. This medication can cause serious metabolic disorders known as diabetic ketoacidosis; if related symptoms (nausea, vomiting, abdominal pain, breathing difficulties, etc.) occur, notify a healthcare professional immediately. Additionally, this medication does not significantly affect driving or operating machinery, but caution is advisable when taken with drugs that have hypoglycemia risk. Finally, this medication has not been proven safe and effective in children, so it should not be used in this population.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, sweating, paleness, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanied respiratory abnormalities, yellowing of skin or eyes (jaundice), profound fatigue, sudden and severe headaches, lightning-like headaches, seizures, confusion, vision abnormalities, paralysis, urination

Mild side effects

• Vulvovaginitis
• balanitis
• genital infections
• urinary tract infections
• fungal infections
• hypoglycemia
• thirst
• dizziness
• constipation
• dry mouth

This medication may be sensitive to air and moisture, so it is important to store it in a tightly sealed container. Moreover, it should be kept at room temperature between 1 and 30 degrees Celsius to maintain efficacy and safety.

Appearance

Yellow, round, double-convex, film-coated tablet in a diamond shape

Package unit

2 blisters/box [(14 tablets/blister) × 2]